HomeCOGT • NASDAQ
add
Cogent Biosciences Inc
Previous close
$11.64
Day range
$11.36 - $11.94
Year range
$3.67 - $12.13
Market cap
1.30B USD
Avg Volume
911.61K
P/E ratio
-
Dividend yield
-
Primary exchange
NASDAQ
Market news
Financials
Income Statement
Revenue
Net income
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Revenue | — | — |
Operating expense | 64.39M | 36.75% |
Net income | -58.95M | -33.75% |
Net profit margin | — | — |
Earnings per share | -0.59 | 0.00% |
EBITDA | -63.78M | -37.10% |
Effective tax rate | — | — |
Balance Sheet
Total assets
Total liabilities
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Cash and short-term investments | 363.22M | 10.27% |
Total assets | 429.94M | 9.57% |
Total liabilities | 56.71M | 29.06% |
Total equity | 373.22M | — |
Shares outstanding | 109.45M | — |
Price to book | 4.91 | — |
Return on assets | -35.53% | — |
Return on capital | -38.68% | — |
Cash Flow
Net change in cash
(USD) | Jun 2024info | Y/Y change |
---|---|---|
Net income | -58.95M | -33.75% |
Cash from operations | -42.70M | -33.17% |
Cash from investing | -84.62M | -8.97% |
Cash from financing | -256.00K | -100.16% |
Net change in cash | -127.58M | -343.64% |
Free cash flow | -26.62M | -56.44% |
About
Founded
2014
Headquarters
Website
Employees
164